Non‐apoptotic regulated cell death mediates reprogramming of the tumour immune microenvironment by macrophages
Tumour immune microenvironment (TIME) plays an indispensable role in tumour progression, and tumour‐associated macrophages (TAMs) are the most abundant immune cells in TIME. Non‐apoptotic regulated cell death (RCD) can avoid the influence of tumour apoptosis resistance on anti‐tumour immune response...
Gespeichert in:
| Veröffentlicht in: | Journal of cellular and molecular medicine 2024-04, Vol.28 (8), p.e18348-n/a |
|---|---|
| Hauptverfasser: | , , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | n/a |
|---|---|
| container_issue | 8 |
| container_start_page | e18348 |
| container_title | Journal of cellular and molecular medicine |
| container_volume | 28 |
| creator | Sun, Chengpeng Zhan, Jianhao Li, Yao Zhou, Chulin Huang, Shuo Zhu, Xingen Huang, Kai |
| description | Tumour immune microenvironment (TIME) plays an indispensable role in tumour progression, and tumour‐associated macrophages (TAMs) are the most abundant immune cells in TIME. Non‐apoptotic regulated cell death (RCD) can avoid the influence of tumour apoptosis resistance on anti‐tumour immune response. Specifically, autophagy, ferroptosis, pyroptosis and necroptosis mediate the crosstalk between TAMs and tumour cells in TIME, thus reprogram TIME and affect the progress of tumour. In addition, although some achievements have been made in immune checkpoint inhibitors (ICIs), there is still defect that ICIs are only effective for some people because non‐apoptotic RCD can bypass the apoptosis resistance of tumour. As a result, ICIs combined with targeting non‐apoptotic RCD may be a promising solution. In this paper, the basic molecular mechanism of non‐apoptotic RCD, the way in which non‐apoptotic RCD mediates crosstalk between TAMs and tumour cells to reprogram TIME, and the latest research progress in targeting non‐apoptotic RCD and ICIs are reviewed. |
| doi_str_mv | 10.1111/jcmm.18348 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_11037416</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>3045117153</sourcerecordid><originalsourceid>FETCH-LOGICAL-c4088-fb30472b7841bacdc862efe7ecbbc3f64d67238412f1238a1187ec1ddd745f713</originalsourceid><addsrcrecordid>eNp9kcFu1DAURS1ERUthwwcgS2wQ0pS82Ek8K1SNKLRqYQNry3FeMh7FcbCTotnxCf1GvoQ3zLQCFnhj692jq-t3GXsB2RnQebux3p-BElI9YidQqHwhl0I-PrxJUMfsaUqbLBMliOUTdixUWeSQFSds_BSGnz_uzBjGKUzO8ojd3JsJG26x73mDZlpzj42jWSJ1jKGLxns3dDy0fFojn2Yf5sid9_OA3DsbAw63LobB4zDxesu9odm4Nh2mZ-yoNX3C54f7lH29eP9l9XFx_fnD5er8emFlptSirUUmq7yulITa2MaqMscWK7R1bUVbyqasckFi3gLdBkCRBk3TVLJoKxCn7N3ed5xrim8pSTS9HqPzJm51ME7_rQxurbtwqwEyUUkoyeH1wSGGbzOmSXuXdksxA4Y5aQpYAFRQCEJf_YNuaCMD_W9HlUsli1IS9WZP0TJSitg-pIFM75rUuyb17yYJfvln_gf0vjoCYA98dz1u_2Olr1Y3N3vTXwdurUA</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>3046984564</pqid></control><display><type>article</type><title>Non‐apoptotic regulated cell death mediates reprogramming of the tumour immune microenvironment by macrophages</title><source>MEDLINE</source><source>DOAJ Directory of Open Access Journals</source><source>Wiley Online Library Journals Frontfile Complete</source><source>Wiley-Blackwell Open Access Titles</source><source>EZB-FREE-00999 freely available EZB journals</source><source>PubMed Central</source><creator>Sun, Chengpeng ; Zhan, Jianhao ; Li, Yao ; Zhou, Chulin ; Huang, Shuo ; Zhu, Xingen ; Huang, Kai</creator><creatorcontrib>Sun, Chengpeng ; Zhan, Jianhao ; Li, Yao ; Zhou, Chulin ; Huang, Shuo ; Zhu, Xingen ; Huang, Kai</creatorcontrib><description>Tumour immune microenvironment (TIME) plays an indispensable role in tumour progression, and tumour‐associated macrophages (TAMs) are the most abundant immune cells in TIME. Non‐apoptotic regulated cell death (RCD) can avoid the influence of tumour apoptosis resistance on anti‐tumour immune response. Specifically, autophagy, ferroptosis, pyroptosis and necroptosis mediate the crosstalk between TAMs and tumour cells in TIME, thus reprogram TIME and affect the progress of tumour. In addition, although some achievements have been made in immune checkpoint inhibitors (ICIs), there is still defect that ICIs are only effective for some people because non‐apoptotic RCD can bypass the apoptosis resistance of tumour. As a result, ICIs combined with targeting non‐apoptotic RCD may be a promising solution. In this paper, the basic molecular mechanism of non‐apoptotic RCD, the way in which non‐apoptotic RCD mediates crosstalk between TAMs and tumour cells to reprogram TIME, and the latest research progress in targeting non‐apoptotic RCD and ICIs are reviewed.</description><identifier>ISSN: 1582-1838</identifier><identifier>EISSN: 1582-4934</identifier><identifier>DOI: 10.1111/jcmm.18348</identifier><identifier>PMID: 38652105</identifier><language>eng</language><publisher>England: John Wiley & Sons, Inc</publisher><subject>Animals ; Apoptosis ; Autophagy ; Cell death ; Fatty acids ; Ferroptosis ; Ferroptosis - immunology ; Genotype & phenotype ; Humans ; Immune checkpoint inhibitors ; Immune Checkpoint Inhibitors - pharmacology ; Immune Checkpoint Inhibitors - therapeutic use ; Immune response ; immunotherapy ; Kinases ; Lipid peroxidation ; Lipids ; Macrophages ; Macrophages - immunology ; Macrophages - metabolism ; Microenvironments ; Mitochondrial DNA ; Molecular modelling ; Morphology ; Necroptosis ; Neoplasms - immunology ; Neoplasms - metabolism ; Neoplasms - pathology ; non‐apoptotic regulated cell death ; Proteins ; Pyroptosis ; Regulated Cell Death ; Review ; Reviews ; Tumor Microenvironment - immunology ; Tumor-Associated Macrophages - immunology ; Tumor-Associated Macrophages - metabolism ; Tumor-Associated Macrophages - pathology ; Tumorigenesis ; Tumors ; tumour immune microenvironment ; tumour‐associated macrophages</subject><ispartof>Journal of cellular and molecular medicine, 2024-04, Vol.28 (8), p.e18348-n/a</ispartof><rights>2024 The Authors. published by Foundation for Cellular and Molecular Medicine and John Wiley & Sons Ltd.</rights><rights>2024 The Authors. Journal of Cellular and Molecular Medicine published by Foundation for Cellular and Molecular Medicine and John Wiley & Sons Ltd.</rights><rights>2024. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c4088-fb30472b7841bacdc862efe7ecbbc3f64d67238412f1238a1187ec1ddd745f713</cites><orcidid>0009-0001-7918-3027</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC11037416/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC11037416/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,727,780,784,864,885,1416,11560,27922,27923,45572,45573,46050,46474,53789,53791</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/38652105$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Sun, Chengpeng</creatorcontrib><creatorcontrib>Zhan, Jianhao</creatorcontrib><creatorcontrib>Li, Yao</creatorcontrib><creatorcontrib>Zhou, Chulin</creatorcontrib><creatorcontrib>Huang, Shuo</creatorcontrib><creatorcontrib>Zhu, Xingen</creatorcontrib><creatorcontrib>Huang, Kai</creatorcontrib><title>Non‐apoptotic regulated cell death mediates reprogramming of the tumour immune microenvironment by macrophages</title><title>Journal of cellular and molecular medicine</title><addtitle>J Cell Mol Med</addtitle><description>Tumour immune microenvironment (TIME) plays an indispensable role in tumour progression, and tumour‐associated macrophages (TAMs) are the most abundant immune cells in TIME. Non‐apoptotic regulated cell death (RCD) can avoid the influence of tumour apoptosis resistance on anti‐tumour immune response. Specifically, autophagy, ferroptosis, pyroptosis and necroptosis mediate the crosstalk between TAMs and tumour cells in TIME, thus reprogram TIME and affect the progress of tumour. In addition, although some achievements have been made in immune checkpoint inhibitors (ICIs), there is still defect that ICIs are only effective for some people because non‐apoptotic RCD can bypass the apoptosis resistance of tumour. As a result, ICIs combined with targeting non‐apoptotic RCD may be a promising solution. In this paper, the basic molecular mechanism of non‐apoptotic RCD, the way in which non‐apoptotic RCD mediates crosstalk between TAMs and tumour cells to reprogram TIME, and the latest research progress in targeting non‐apoptotic RCD and ICIs are reviewed.</description><subject>Animals</subject><subject>Apoptosis</subject><subject>Autophagy</subject><subject>Cell death</subject><subject>Fatty acids</subject><subject>Ferroptosis</subject><subject>Ferroptosis - immunology</subject><subject>Genotype & phenotype</subject><subject>Humans</subject><subject>Immune checkpoint inhibitors</subject><subject>Immune Checkpoint Inhibitors - pharmacology</subject><subject>Immune Checkpoint Inhibitors - therapeutic use</subject><subject>Immune response</subject><subject>immunotherapy</subject><subject>Kinases</subject><subject>Lipid peroxidation</subject><subject>Lipids</subject><subject>Macrophages</subject><subject>Macrophages - immunology</subject><subject>Macrophages - metabolism</subject><subject>Microenvironments</subject><subject>Mitochondrial DNA</subject><subject>Molecular modelling</subject><subject>Morphology</subject><subject>Necroptosis</subject><subject>Neoplasms - immunology</subject><subject>Neoplasms - metabolism</subject><subject>Neoplasms - pathology</subject><subject>non‐apoptotic regulated cell death</subject><subject>Proteins</subject><subject>Pyroptosis</subject><subject>Regulated Cell Death</subject><subject>Review</subject><subject>Reviews</subject><subject>Tumor Microenvironment - immunology</subject><subject>Tumor-Associated Macrophages - immunology</subject><subject>Tumor-Associated Macrophages - metabolism</subject><subject>Tumor-Associated Macrophages - pathology</subject><subject>Tumorigenesis</subject><subject>Tumors</subject><subject>tumour immune microenvironment</subject><subject>tumour‐associated macrophages</subject><issn>1582-1838</issn><issn>1582-4934</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2024</creationdate><recordtype>article</recordtype><sourceid>24P</sourceid><sourceid>WIN</sourceid><sourceid>EIF</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>AZQEC</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><sourceid>DWQXO</sourceid><sourceid>GNUQQ</sourceid><recordid>eNp9kcFu1DAURS1ERUthwwcgS2wQ0pS82Ek8K1SNKLRqYQNry3FeMh7FcbCTotnxCf1GvoQ3zLQCFnhj692jq-t3GXsB2RnQebux3p-BElI9YidQqHwhl0I-PrxJUMfsaUqbLBMliOUTdixUWeSQFSds_BSGnz_uzBjGKUzO8ojd3JsJG26x73mDZlpzj42jWSJ1jKGLxns3dDy0fFojn2Yf5sid9_OA3DsbAw63LobB4zDxesu9odm4Nh2mZ-yoNX3C54f7lH29eP9l9XFx_fnD5er8emFlptSirUUmq7yulITa2MaqMscWK7R1bUVbyqasckFi3gLdBkCRBk3TVLJoKxCn7N3ed5xrim8pSTS9HqPzJm51ME7_rQxurbtwqwEyUUkoyeH1wSGGbzOmSXuXdksxA4Y5aQpYAFRQCEJf_YNuaCMD_W9HlUsli1IS9WZP0TJSitg-pIFM75rUuyb17yYJfvln_gf0vjoCYA98dz1u_2Olr1Y3N3vTXwdurUA</recordid><startdate>202404</startdate><enddate>202404</enddate><creator>Sun, Chengpeng</creator><creator>Zhan, Jianhao</creator><creator>Li, Yao</creator><creator>Zhou, Chulin</creator><creator>Huang, Shuo</creator><creator>Zhu, Xingen</creator><creator>Huang, Kai</creator><general>John Wiley & Sons, Inc</general><general>John Wiley and Sons Inc</general><scope>24P</scope><scope>WIN</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7QP</scope><scope>7TK</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>88I</scope><scope>8AO</scope><scope>8FD</scope><scope>8FE</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FR3</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>LK8</scope><scope>M0S</scope><scope>M1P</scope><scope>M2P</scope><scope>M7P</scope><scope>P64</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>Q9U</scope><scope>RC3</scope><scope>7X8</scope><scope>5PM</scope><orcidid>https://orcid.org/0009-0001-7918-3027</orcidid></search><sort><creationdate>202404</creationdate><title>Non‐apoptotic regulated cell death mediates reprogramming of the tumour immune microenvironment by macrophages</title><author>Sun, Chengpeng ; Zhan, Jianhao ; Li, Yao ; Zhou, Chulin ; Huang, Shuo ; Zhu, Xingen ; Huang, Kai</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c4088-fb30472b7841bacdc862efe7ecbbc3f64d67238412f1238a1187ec1ddd745f713</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2024</creationdate><topic>Animals</topic><topic>Apoptosis</topic><topic>Autophagy</topic><topic>Cell death</topic><topic>Fatty acids</topic><topic>Ferroptosis</topic><topic>Ferroptosis - immunology</topic><topic>Genotype & phenotype</topic><topic>Humans</topic><topic>Immune checkpoint inhibitors</topic><topic>Immune Checkpoint Inhibitors - pharmacology</topic><topic>Immune Checkpoint Inhibitors - therapeutic use</topic><topic>Immune response</topic><topic>immunotherapy</topic><topic>Kinases</topic><topic>Lipid peroxidation</topic><topic>Lipids</topic><topic>Macrophages</topic><topic>Macrophages - immunology</topic><topic>Macrophages - metabolism</topic><topic>Microenvironments</topic><topic>Mitochondrial DNA</topic><topic>Molecular modelling</topic><topic>Morphology</topic><topic>Necroptosis</topic><topic>Neoplasms - immunology</topic><topic>Neoplasms - metabolism</topic><topic>Neoplasms - pathology</topic><topic>non‐apoptotic regulated cell death</topic><topic>Proteins</topic><topic>Pyroptosis</topic><topic>Regulated Cell Death</topic><topic>Review</topic><topic>Reviews</topic><topic>Tumor Microenvironment - immunology</topic><topic>Tumor-Associated Macrophages - immunology</topic><topic>Tumor-Associated Macrophages - metabolism</topic><topic>Tumor-Associated Macrophages - pathology</topic><topic>Tumorigenesis</topic><topic>Tumors</topic><topic>tumour immune microenvironment</topic><topic>tumour‐associated macrophages</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Sun, Chengpeng</creatorcontrib><creatorcontrib>Zhan, Jianhao</creatorcontrib><creatorcontrib>Li, Yao</creatorcontrib><creatorcontrib>Zhou, Chulin</creatorcontrib><creatorcontrib>Huang, Shuo</creatorcontrib><creatorcontrib>Zhu, Xingen</creatorcontrib><creatorcontrib>Huang, Kai</creatorcontrib><collection>Wiley-Blackwell Open Access Titles</collection><collection>Wiley Free Content</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Calcium & Calcified Tissue Abstracts</collection><collection>Neurosciences Abstracts</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Science Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Technology Research Database</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>ProQuest Central</collection><collection>Natural Science Collection</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Engineering Research Database</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>ProQuest Biological Science Collection</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Science Database</collection><collection>Biological Science Database</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>Publicly Available Content Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>ProQuest Central Basic</collection><collection>Genetics Abstracts</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Journal of cellular and molecular medicine</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Sun, Chengpeng</au><au>Zhan, Jianhao</au><au>Li, Yao</au><au>Zhou, Chulin</au><au>Huang, Shuo</au><au>Zhu, Xingen</au><au>Huang, Kai</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Non‐apoptotic regulated cell death mediates reprogramming of the tumour immune microenvironment by macrophages</atitle><jtitle>Journal of cellular and molecular medicine</jtitle><addtitle>J Cell Mol Med</addtitle><date>2024-04</date><risdate>2024</risdate><volume>28</volume><issue>8</issue><spage>e18348</spage><epage>n/a</epage><pages>e18348-n/a</pages><issn>1582-1838</issn><eissn>1582-4934</eissn><abstract>Tumour immune microenvironment (TIME) plays an indispensable role in tumour progression, and tumour‐associated macrophages (TAMs) are the most abundant immune cells in TIME. Non‐apoptotic regulated cell death (RCD) can avoid the influence of tumour apoptosis resistance on anti‐tumour immune response. Specifically, autophagy, ferroptosis, pyroptosis and necroptosis mediate the crosstalk between TAMs and tumour cells in TIME, thus reprogram TIME and affect the progress of tumour. In addition, although some achievements have been made in immune checkpoint inhibitors (ICIs), there is still defect that ICIs are only effective for some people because non‐apoptotic RCD can bypass the apoptosis resistance of tumour. As a result, ICIs combined with targeting non‐apoptotic RCD may be a promising solution. In this paper, the basic molecular mechanism of non‐apoptotic RCD, the way in which non‐apoptotic RCD mediates crosstalk between TAMs and tumour cells to reprogram TIME, and the latest research progress in targeting non‐apoptotic RCD and ICIs are reviewed.</abstract><cop>England</cop><pub>John Wiley & Sons, Inc</pub><pmid>38652105</pmid><doi>10.1111/jcmm.18348</doi><tpages>21</tpages><orcidid>https://orcid.org/0009-0001-7918-3027</orcidid><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 1582-1838 |
| ispartof | Journal of cellular and molecular medicine, 2024-04, Vol.28 (8), p.e18348-n/a |
| issn | 1582-1838 1582-4934 |
| language | eng |
| recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_11037416 |
| source | MEDLINE; DOAJ Directory of Open Access Journals; Wiley Online Library Journals Frontfile Complete; Wiley-Blackwell Open Access Titles; EZB-FREE-00999 freely available EZB journals; PubMed Central |
| subjects | Animals Apoptosis Autophagy Cell death Fatty acids Ferroptosis Ferroptosis - immunology Genotype & phenotype Humans Immune checkpoint inhibitors Immune Checkpoint Inhibitors - pharmacology Immune Checkpoint Inhibitors - therapeutic use Immune response immunotherapy Kinases Lipid peroxidation Lipids Macrophages Macrophages - immunology Macrophages - metabolism Microenvironments Mitochondrial DNA Molecular modelling Morphology Necroptosis Neoplasms - immunology Neoplasms - metabolism Neoplasms - pathology non‐apoptotic regulated cell death Proteins Pyroptosis Regulated Cell Death Review Reviews Tumor Microenvironment - immunology Tumor-Associated Macrophages - immunology Tumor-Associated Macrophages - metabolism Tumor-Associated Macrophages - pathology Tumorigenesis Tumors tumour immune microenvironment tumour‐associated macrophages |
| title | Non‐apoptotic regulated cell death mediates reprogramming of the tumour immune microenvironment by macrophages |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-14T01%3A42%3A17IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Non%E2%80%90apoptotic%20regulated%20cell%20death%20mediates%20reprogramming%20of%20the%20tumour%20immune%20microenvironment%20by%20macrophages&rft.jtitle=Journal%20of%20cellular%20and%20molecular%20medicine&rft.au=Sun,%20Chengpeng&rft.date=2024-04&rft.volume=28&rft.issue=8&rft.spage=e18348&rft.epage=n/a&rft.pages=e18348-n/a&rft.issn=1582-1838&rft.eissn=1582-4934&rft_id=info:doi/10.1111/jcmm.18348&rft_dat=%3Cproquest_pubme%3E3045117153%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=3046984564&rft_id=info:pmid/38652105&rfr_iscdi=true |